A UK consensus statement on thromboprophylaxis for autologous breast reconstruction.

[1]  Daohai Yu,et al.  Safe perioperative tamoxifen use in autologous breast free flap reconstruction: systematic review and meta-analysis , 2022, Breast Cancer Research and Treatment.

[2]  M. Crowley,et al.  A novel algorithm to reduce VTE in peri-operative patients on tamoxifen , 2021, Breast.

[3]  P. Harris,et al.  Reducing postoperative venous thromboembolism in DIEP free flap breast reconstruction: Extended pharmacological thromboprophylaxis within an enhanced recovery programme. , 2021, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[4]  J. Benson,et al.  Microvascular breast reconstruction and thromboembolic events in patients on hormone therapy: Audit of practice from a tertiary referral centre. , 2020, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[5]  G. Christopoulos,et al.  The use of bi-pedicled DIEP flap for unilateral breast reconstruction: a 5-year retrospective study , 2020, European Journal of Plastic Surgery.

[6]  C. Pannucci,et al.  Venous Thromboembolism following Microsurgical Breast Reconstruction: A Longitudinal Analysis of 12,778 Patients , 2020, Plastic and reconstructive surgery.

[7]  A. Davies,et al.  Graduated compression stockings as adjuvant to pharmaco-thromboprophylaxis in elective surgical patients (GAPS study): randomised controlled trial , 2020, BMJ.

[8]  Gedge D. Rosson,et al.  Pre-, intra-, and/or postoperative arterial and venous thromboembolism prophylaxis for breast surgery: Systematic review and meta-analysis. , 2019, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[9]  Tito D. Tubog.  Combined Intermittent Pneumatic Leg Compression and Pharmacological Prophylaxis for Prevention of Venous Thromboembolism , 2019, Orthopedic nursing.

[10]  J. Serletti,et al.  Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based Microsurgical Breast Reconstruction? , 2018, Plastic and reconstructive surgery.

[11]  M. Jones,et al.  Improved patient outcomes using the enhanced recovery pathway in breast microsurgical reconstruction: a UK experience , 2018, JPRAS open.

[12]  Bernard T. Lee,et al.  Does Hormone Therapy Use Increase Perioperative Complications in Abdominally Based Microsurgical Breast Reconstruction? , 2018, Plastic and reconstructive surgery.

[13]  F. Henry,et al.  Thromboprophylaxis in autologous breast reconstruction. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[14]  R. Bosc,et al.  Impact of adjuvant anti-estrogen therapies (tamoxifen and aromatase inhibitors) on perioperative outcomes of breast reconstruction. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[15]  P. Harris,et al.  Audit of venous thromboembolism in DIEP free flap breast reconstruction. , 2017, Journal of plastic, reconstructive & aesthetic surgery : JPRAS.

[16]  G. Colditz,et al.  Complications and thromboembolic events associated with tamoxifen therapy in patients with breast cancer undergoing microvascular breast reconstruction: a systematic review and meta-analysis , 2017, Breast Cancer Research and Treatment.

[17]  T. Pérez-de la Fuente.  Is It Necessary to Stop Tamoxifen Therapy in Microvascular Flap Breast Reconstruction? , 2017, Annals of plastic surgery.

[18]  G. Evans,et al.  The Effects of Perioperative Tamoxifen Therapy on Microvascular Flap Complications in Transverse Rectus Abdominis Myocutaneous/Deep Inferior Epigastric Perforator Flap Breast Reconstruction , 2016, Annals of plastic surgery.

[19]  Agnes Y. Y. Lee,et al.  Role of Extended Thromboprophylaxis After Abdominal and Pelvic Surgery in Cancer Patients: A Systematic Review and Meta-Analysis , 2015, Annals of Surgical Oncology.

[20]  Suhail K. Kanchwala,et al.  Tamoxifen (Selective Estrogen-Receptor Modulators) and Aromatase Inhibitors as Potential Perioperative Thrombotic Risk Factors in Free Flap Breast Reconstruction , 2015, Plastic and reconstructive surgery.

[21]  Ashley K Stromich.  Unfractionated Heparin and Low Molecular Weight Heparin , 2015 .

[22]  J. Fischer,et al.  Venous Thromboembolism Risk in Mastectomy and Immediate Breast Reconstruction: Analysis of the 2005 to 2011 American College of Surgeons National Surgical Quality Improvement Program Data Sets , 2014, Plastic and reconstructive surgery.

[23]  G. Evans,et al.  Predictive Risk Factors of Venous Thromboembolism in Autologous Breast Reconstruction Surgery , 2014, Annals of plastic surgery.

[24]  K. Ho,et al.  Stratified Meta-Analysis of Intermittent Pneumatic Compression of the Lower Limbs to Prevent Venous Thromboembolism in Hospitalized Patients , 2013, Circulation.

[25]  R. Timman,et al.  Pulmonary Embolism after Abdominal Flap Breast Reconstruction: Prediction and Prevention , 2013, Plastic and reconstructive surgery.

[26]  P. Vogt,et al.  Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction? , 2013, German medical science : GMS e-journal.

[27]  J. Fischer,et al.  Perioperative Hemodynamics in Free Flap Breast Reconstruction: Incidence, Predictors, and Management of Tachycardia , 2012, Annals of plastic surgery.

[28]  V. Valero,et al.  Tamoxifen Increases the Risk of Microvascular Flap Complications in Patients Undergoing Microvascular Breast Reconstruction , 2012, Plastic and reconstructive surgery.

[29]  P. Cordeiro,et al.  Venous Thromboembolism following Microsurgical Breast Reconstruction: An Objective Analysis in 225 Consecutive Patients Using Low-Molecular-Weight Heparin Prophylaxis , 2011, Plastic and reconstructive surgery.

[30]  J. Caprini.  Risk assessment as a guide to thrombosis prophylaxis , 2010, Current opinion in pulmonary medicine.

[31]  S. Davison,et al.  Prevention of venous thromboembolism in the plastic surgery patient: current guidelines and recommendations. , 2009, Aesthetic surgery journal.

[32]  Eun Key Kim,et al.  The Efficacy of Prophylactic Low-Molecular-Weight Heparin to Prevent Pulmonary Thromboembolism in Immediate Breast Reconstruction Using the TRAM Flap , 2009, Plastic and reconstructive surgery.

[33]  S. Goldhaber.  Tamoxifen: preventing breast cancer and placing the risk of deep vein thrombosis in perspective. , 2005, Circulation.

[34]  J. Caprini.  Thrombosis risk assessment as a guide to quality patient care. , 2005, Disease-a-month : DM.

[35]  C. Attinger,et al.  Prevention of Venous Thromboembolism in the Plastic Surgery Patient , 2004, Plastic and reconstructive surgery.

[36]  D. Hoppensteadt,et al.  Pharmacodynamic and Pharmacokinetic Properties of Enoxaparin , 2003, Clinical pharmacokinetics.

[37]  J. Hasty,et al.  Venous thromboembolism prophylaxis and risk assessment in medical patients. , 1991, Seminars in thrombosis and hemostasis.